Dupont Jakob

Track

Insider profile

Dupont Jakob's trades of Pyxis Oncology Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Planned sale
Price
197.07
Quantity 97,337 +27.4%
Value US$3,972,402
Transaction date
Proposed sale
Price
106.23
Quantity 50,350
Value US$2,628,056
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-07-02 2026-06-30
PlS Planned sale
97,337 +27.4%
197.07
US$3,972,402 		97,337 +27.4% 197.07 US$3,972,402
2026-06-30 2026-06-30
PrS Proposed sale
50,350
106.23
US$2,628,056 		50,350 106.23 US$2,628,056
2023-03-06 2023-03-02
PlS Planned sale
25,582 -34.1%
327.18
US$3,845,515 		25,582 -34.1% 327.18 US$3,845,515
2022-11-18 2022-11-16
PlS Planned sale
1,124 -0.7%
4.49
US$5,048 		1,124 -0.7% 4.49 US$5,048
2022-11-18 2022-11-16
PlS Planned sale
3,218 -2.0%
4.49
US$14,449 		3,218 -2.0% 4.49 US$14,449
2022-08-18 2022-08-16
PlS Planned sale
4,124 -2.5%
5.03
US$20,760 		4,124 -2.5% 5.03 US$20,760
2022-05-19 2022-05-17
PlS Planned sale
3,873 -2.3%
5.32
US$20,597 		3,873 -2.3% 5.32 US$20,597
2022-03-03 2022-03-01
PlS Planned sale
2,221 -1.3%
9.86
US$21,890 		2,221 -1.3% 9.86 US$21,890
2022-02-14 2022-02-10
PlS Planned sale
5,000 -5.2%
16.00
US$80,000 		5,000 -5.2% 16.00 US$80,000
2022-01-05 2022-01-03
PlS Planned sale
5,000 -5.2%
16.01
US$80,050 		5,000 -5.2% 16.01 US$80,050
2021-12-03 2021-12-01
PlS Planned sale
5,000 -5.2%
17.94
US$89,688 		5,000 -5.2% 17.94 US$89,688
2021-11-18 2021-11-16
PlS Planned sale
2,199 -2.4%
17.12
US$37,640 		2,199 -2.4% 17.12 US$37,640
2021-11-04 2021-11-02
PlS Planned sale
5,000 -5.1%
16.41
US$82,050 		5,000 -5.1% 16.41 US$82,050
2021-05-20 2021-05-18
PlS Planned sale
5,184 -5.2%
14.55
US$75,427 		5,184 -5.2% 14.55 US$75,427